Efficacy and safety of the Gam-COVID-Vac in patients with immunoinflammatory rheumatic diseases: preliminary data of prospective study | Kulikov | Modern Rheumatology Journal

Modern Rheumatology Journal
Sovremennaâ revmatologiâ

ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)

eng | рус

Preview

Modern Rheumatology Journal

Advanced search

Archives

Download this PDF file

For citations:

Kulikov AN, Muravyeva NV, Belov BS, Gridneva GI, Aronova ES. Efficacy and safety of the Gam-COVID-Vac in patients with immunoinflammatory rheumatic diseases: preliminary data of prospective study. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2023;17(6):72-78. (In Russ.) https://doi.org/10.14412/1996-7012-2023-6-72-78

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Al. M. Lila

Article Tools

Indexing metadata

How to cite item

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

A. N. Kulikov
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

34A, Kashirskoye Shosse, Moscow, 115522

N. V. Muravyeva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

34A, Kashirskoye Shosse, Moscow, 115522

B. S. Belov
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

34A, Kashirskoye Shosse, Moscow, 115522

G. I. Gridneva
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

34A, Kashirskoye Shosse, Moscow, 115522

E. S. Aronova
V.A. Nasonova Research Institute of Rheumatology
Russian Federation

34A, Kashirskoye Shosse, Moscow, 115522

Notifications

Авторам